Huang et al. showed that SERPINB2 plays a role in acquired cisplatin resistance in head and neck cancers, and that upregulation of SERPINB2 can enhance sensitivity to cisplatin [37]. This evidence concerns the gene SERPINB2 and head and neck cancer.